Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
50.30B
Market cap50.30B
Price-Earnings ratio
47.46
Price-Earnings ratio47.46
Dividend yield
Dividend yield
Average volume
4.69M
Average volume4.69M
High today
$87.83
High today$87.83
Low today
$86.57
Low today$86.57
Open price
$86.91
Open price$86.91
Volume
5.41M
Volume5.41M
52 Week high
$89.60
52 Week high$89.60
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $87.35, with a market capitalization of 50.3B. The stock trades at a price-to-earnings (P/E) ratio of 47.46.

During the trading session on 2026-06-19, Edwards Lifesciences(EW) shares reached a daily high of $87.83 and a low of $86.57. At a current price of $87.35, the stock is +0.9% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 5.41M, compared to an average daily volume of 4.69M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $89.60 and a low of $72.30.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $89.60 and a low of $72.30.

EW News

Simply Wall St 2d
Does Expanded CMS TAVR Coverage Alter the Bull Case for Edwards Lifesciences?

The Centers for Medicare & Medicaid Services previously issued an updated National Coverage Determination that broadened access to transcatheter aortic valve re...

Does Expanded CMS TAVR Coverage Alter the Bull Case for Edwards Lifesciences?
Benzinga 3d
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

On Monday, the Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aorti...

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device
Simply Wall St 4d
Edwards Lifesciences Stock Could Be 11% Undervalued on Its TAVR and EVOQUE Story

Edwards Lifesciences (EW) stock has drawn fresh attention as investors review its recent performance and financial profile, including a last close of $86.28 and...

Edwards Lifesciences Stock Could Be 11% Undervalued on Its TAVR and EVOQUE Story

Analyst ratings

76%

of 33 ratings
Buy
75.8%
Hold
24.2%
Sell
0%

More EW News

TipRanks 4d
Edwards Lifesciences Buy Rating Reaffirmed as Favorable TAVR Policy Update Supports Growth and $100 Price Target Maintained

Edwards Lifesciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis Steed from Bank of America Securities main...

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.